OTUB1 inhibits CNS autoimmunity by preventing IFN-γ-induced hyperactivation of astrocytes.
Name:
Wang et al.pdf
Size:
3.409Mb
Format:
PDF
Description:
delayed Open Access publication
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Wang, XuMulas, Floriana
Yi, Wenjing
Brunn, Anna
Nishanth, Gopala
Just, Sissy
Waisman, Ari
Brück, Wolfgang
Deckert, Martina
Schlüter, Dirk
Issue Date
2019-04-03
Metadata
Show full item recordAbstract
Astrocytes are critical regulators of neuroinflammation in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Growing evidence indicates that ubiquitination of signaling molecules is an important cell-intrinsic mechanism governing astrocyte function during MS and EAE Here, we identified an upregulation of the deubiquitinase OTU domain, ubiquitin aldehyde binding 1 (OTUB1) in astrocytes during MS and EAE Mice with astrocyte-specific OTUB1 ablation developed more severe EAE due to increased leukocyte accumulation, proinflammatory gene transcription, and demyelination in the spinal cord as compared to control mice. OTUB1-deficient astrocytes were hyperactivated in response to IFN-γ, a fingerprint cytokine of encephalitogenic T cells, and produced more proinflammatory cytokines and chemokines than control astrocytes. Mechanistically, OTUB1 inhibited IFN-γ-induced Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling by K48 deubiquitination and stabilization of the JAK2 inhibitor suppressor of cytokine signaling 1 (SOCS1). Thus, astrocyte-specific OTUB1 is a critical inhibitor of neuroinflammation in CNS autoimmunity.Citation
EMBO J. 2019;38(10):e100947. doi:10.15252/embj.2018100947.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
EMBO PressJournal
The EMBO journalPubMed ID
30944096Type
ArticleOther
Language
enEISSN
1460-2075ae974a485f413a2113503eed53cd6c53
10.15252/embj.2018100947
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
- Authors: Smith BC, Sinyuk M, Jenkins JE 3rd, Psenicka MW, Williams JL
- Issue date: 2020 Jun 12
- Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
- Authors: Haroon F, Drögemüller K, Händel U, Brunn A, Reinhold D, Nishanth G, Mueller W, Trautwein C, Ernst M, Deckert M, Schlüter D
- Issue date: 2011 Jun 1
- Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
- Authors: Ding X, Yan Y, Li X, Li K, Ciric B, Yang J, Zhang Y, Wu S, Xu H, Chen W, Lovett-Racke AE, Zhang GX, Rostami A
- Issue date: 2015 May 1
- Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity.
- Authors: Yi W, Schlüter D, Wang X
- Issue date: 2019 Aug
- Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis.
- Authors: Glabinski AR, Krakowski M, Han Y, Owens T, Ransohoff RM
- Issue date: 1999 Feb